Return to Video

vimeo.com/.../277682681

  • 0:22 - 0:26
    My name is Dr. Moses deGraft-Johnson.
  • 0:26 - 0:28
    The term “assistive technology” is defined
  • 0:28 - 0:32
    by the World Health Organization (WHO)
  • 0:32 - 0:35
    as an umbrella term that covers
  • 0:35 - 0:37
    systems and services that are related to
  • 0:37 - 0:40
    the delivery of assistive products and
  • 0:40 - 0:43
    services, and the whole purpose
  • 0:43 - 0:45
    of this is to aid an individual by giving
  • 0:45 - 0:47
    them independence and promoting their
  • 0:47 - 0:50
    overall well-being.
  • 0:50 - 0:53
    Now, as my colleague here just showed us
  • 0:53 - 0:57
    some very cool innovations,
  • 0:57 - 1:00
    some of the innovations that we
  • 1:00 - 1:02
    are very familiar with are the simplest
  • 1:02 - 1:05
    things such as the hearing aids,
  • 1:05 - 1:07
    wheelchairs, and the prosthesis. Even
  • 1:07 - 1:09
    something as simple as pill organizers,
  • 1:09 - 1:12
    because this is something even people
  • 1:12 - 1:15
    without a true disability utilize, you
  • 1:15 - 1:20
    know? My mother utilizes pill organizers.
  • 1:20 - 1:21
    So we find that there are certain
  • 1:21 - 1:23
    assistive technologies that even
  • 1:23 - 1:25
    individuals who do not have a true
  • 1:25 - 1:29
    disability also utilize in their daily
  • 1:29 - 1:32
    lives. And we’re seeing more and more
  • 1:32 - 1:34
    of that globally; more than
  • 1:34 - 1:35
    one billion people need one or more
  • 1:35 - 1:39
    assistive products.
  • 1:40 - 1:42
    Now this is the part that I really want to
  • 1:42 - 1:49
    get into, because this really talks about
  • 1:49 - 1:50
    what I do for a living,
  • 1:50 - 1:53
    and recently what we’ve seen is that the
  • 1:53 - 1:55
    World Health Organization released some
  • 1:55 - 1:59
    data, and what we see is a rise in
  • 1:59 - 2:01
    non-communicable diseases that are
  • 2:01 - 2:06
    causing persons with disability.
  • 2:06 - 2:09
    And one of the most common ones that was
  • 2:09 - 2:13
    mentioned was diabetes. But also, along
  • 2:13 - 2:16
    with diabetes was hypertension and
  • 2:16 - 2:18
    hyperlipidemia, also known simply
  • 2:18 - 2:22
    as high cholesterol, obesity, and smoking.
  • 2:22 - 2:25
    Now what’s interesting is that these five
  • 2:25 - 2:30
    variables are also known in cardiovascular
  • 2:30 - 2:34
    medicine as the five major risk factors
  • 2:34 - 2:36
    for a major cardiovascular event
  • 2:36 - 2:41
    They lead to something called
    atheromatous plaque.
  • 2:41 - 2:44
    This is plaque formation of buildup in
  • 2:44 - 2:48
    our blood vessels. This is an example of a
  • 2:48 - 2:51
    normal coronary artery in the heart,
  • 2:51 - 2:55
    and as we see, over time we get damages,
  • 2:55 - 2:58
    buildups, and eventually we have lack of
  • 2:58 - 3:00
    perfusion, or lack of blood flow.
  • 3:00 - 3:02
    And that’s what eventually leads to heart
  • 3:02 - 3:05
    attacks, strokes, and poor circulation,
  • 3:05 - 3:07
    commonly known as “P-A-D.”
  • 3:07 - 3:09
    Now, at the Heart and Vascular Institute,
  • 3:09 - 3:11
    what we have done is we have an
  • 3:11 - 3:16
    initiative called the
    "Save a Limb Initiative."
  • 3:16 - 3:19
    One of the things that my goal was was to
  • 3:19 - 3:22
    at least limit the amount of amputations
  • 3:22 - 3:26
    that were occurring in that community.
  • 3:26 - 3:28
    When we see patients who have these
  • 3:28 - 3:30
    sorts of problems, the first thing we
  • 3:30 - 3:33
    do after we’ve assessed them is called
  • 3:33 - 3:35
    acute limb ischemia. We take them
  • 3:35 - 3:37
    into the operating room and utilize a
  • 3:37 - 3:41
    GE system called a C-ARM.
  • 3:42 - 3:44
    What it does is it’s an X-ray that takes
  • 3:44 - 3:47
    pictures of the legs from the bellybutton
  • 3:47 - 3:49
    all the way down to the feet.
  • 3:49 - 3:53
    We use contrast dye to inject into the
  • 3:53 - 3:57
    patients so it will allow us to give us an
  • 3:57 - 3:59
    image, sort of like this.
  • 3:59 - 4:01
    So this first picture here… clearly you
  • 4:01 - 4:03
    don’t need to be a doctor to see there’s a
  • 4:03 - 4:06
    significant problem here. This is called
  • 4:06 - 4:08
    This is called the superficial femoral
  • 4:08 - 4:11
    artery. this is the big vessel that lies
  • 4:11 - 4:13
    between your hip and your knee.
  • 4:13 - 4:16
    It’s like a highway that’s not complete
  • 4:16 - 4:19
    because there’s something missing here,
  • 4:19 - 4:21
    right in the middle.
  • 4:21 - 4:23
    So this individual has developed a
  • 4:23 - 4:25
    blockage in that blood vessel that has
  • 4:25 - 4:28
    definitely caused a total occlusion of
  • 4:28 - 4:30
    blood flow flowing from this part,
  • 4:30 - 4:33
    which is coming from the belly button area
  • 4:33 - 4:35
    going down to the knee.
  • 4:35 - 4:37
    So once we take that picture with that GE
  • 4:37 - 4:40
    system, I’m able to see this and initial,
  • 4:40 - 4:44
    and right here I’m able to, just like a
  • 4:44 - 4:48
    plumber does, you know, you
    snake the pipes.
  • 4:48 - 4:51
    So here you have a specific type of water
  • 4:51 - 4:55
    system that I use to cross the artery.
  • 4:55 - 4:58
    And once I cross the water system, on this
  • 4:58 - 5:02
    side… I’m going to show you this picture
  • 5:02 - 5:04
    here… I use a system called
  • 5:04 - 5:06
    a jetstream atherectomy device.
  • 5:06 - 5:09
    Now this system is a system that is made
  • 5:09 - 5:11
    by a company called Boston Scientific.
  • 5:11 - 5:13
    Boston Scientific is a medical device
  • 5:13 - 5:15
    company based out of
  • 5:15 - 5:19
    Maple Grove Minneapolis, in Minnesota.
  • 5:19 - 5:21
    And what it is is that basically we use
  • 5:21 - 5:23
    this device, it’s like a drilling system.
  • 5:23 - 5:27
    Just like in the oil fields, they drill
  • 5:27 - 5:30
    the ground. We use this system over that
  • 5:30 - 5:33
    wire that I’ve put into the system and
  • 5:33 - 5:36
    we’re able to go over the wire and clean
  • 5:36 - 5:40
    out the plaques that have formed.
  • 5:40 - 5:42
    Once that plaque is cleaned out, we use a
  • 5:42 - 5:45
    balloon system to stretch out the
  • 5:45 - 5:47
    blood vessels to really give it a wide
  • 5:47 - 5:51
    opening, and sometimes once it stays open,
  • 5:51 - 5:53
    if it stays open it’s fine but if it
  • 5:53 - 5:55
    doesn’t stay open, it has a tendency
  • 5:55 - 5:57
    to constrict again, and that’s when
  • 5:57 - 6:00
    we have a tendency to put in a stent
  • 6:00 - 6:05
    to keep it open. So in this picture right
  • 6:05 - 6:08
    here, this diagram, you see that we were
  • 6:08 - 6:12
    successful opening up this total occlusion
  • 6:12 - 6:15
    here, and opening it up and restoring
  • 6:15 - 6:19
    blood flow back to the limb.
  • 6:23 - 6:26
    This is an actual photograph of one of my
  • 6:26 - 6:31
    patients. Unfortunately, this was a
  • 6:31 - 6:33
    gentleman that we were not able to save
  • 6:33 - 6:36
    his leg. So this is six weeks
  • 6:36 - 6:39
    after surgery after I amputated.
  • 6:39 - 6:41
    This is called a BKA, a below the knee
  • 6:41 - 6:46
    amputation. And I often say that if
  • 6:46 - 6:49
    you’re not fortunate enough for me to save
  • 6:49 - 6:50
    the limb, I’d rather you have a
  • 6:50 - 6:53
    below the knee amputation versus
  • 6:53 - 6:57
    above the knee amputation, because
  • 6:57 - 7:00
    functionality-wise it’s better for the
  • 7:00 - 7:02
    individual because we’re able to really
  • 7:02 - 7:04
    fit him very well with a good prosthesis,
  • 7:04 - 7:07
    that they can go back and handle it and
  • 7:07 - 7:09
    walk as if nothing ever happened.
  • 7:09 - 7:11
    But it becomes a huge challenge once you
  • 7:11 - 7:15
    go above the knee. It’s very hard to fit
  • 7:15 - 7:17
    someone for any good prosthesis,
  • 7:17 - 7:21
    for them to bear weight.
  • 7:21 - 7:23
    We call this the “stump line.”
  • 7:23 - 7:25
    And we have a tendency to have a lot of
  • 7:25 - 7:27
    breakdown on this stump line.
  • 7:27 - 7:29
    So it just makes things a little bit
  • 7:29 - 7:31
    difficult. So unfortunately, I was not
  • 7:31 - 7:34
    able to save this man’s leg sine we had
  • 7:34 - 7:39
    the surgery, and this is him and his wife
  • 7:39 - 7:42
    after surgery.
  • 7:42 - 7:43
    So this is the sort of assistive
  • 7:43 - 7:47
    technology we’re used to seeing.
  • 7:47 - 7:49
    And in the past, I have to admit,
  • 7:49 - 7:52
    I have to be clear and be honest with you,
  • 7:52 - 7:53
    I never really paid attention to a lot of
  • 7:53 - 7:55
    this stuff until I met Chet Cooper.
  • 7:55 - 7:57
    That’s when I started to really focus and
  • 7:57 - 7:58
    pay attention to these things.
  • 7:58 - 8:01
    They’re right in front of us, they’re
  • 8:01 - 8:03
    right around us, but we’re so busy with
  • 8:03 - 8:05
    our daily lives we don’t pay attention to
  • 8:05 - 8:07
    things that are happening.
  • 8:07 - 8:10
    But this is now a big problem and a part
  • 8:10 - 8:14
    of my practice right now, of what I do.
  • 8:14 - 8:16
    So once we have saved the limb,
  • 8:16 - 8:18
    the question is then how do you prevent
  • 8:18 - 8:21
    them from ending up like this gentleman.
  • 8:21 - 8:26
    So we have a technology called the SPY.
  • 8:26 - 8:28
    The SPY was developed by a company
  • 8:28 - 8:30
    called Novadaq and then they sold it off
  • 8:30 - 8:32
    to a company called Stryker.
  • 8:32 - 8:34
    Stryker is a big medical device company
  • 8:34 - 8:36
    that does a lot of spine surgery for
  • 8:36 - 8:38
    people with back problems and this sort
  • 8:38 - 8:40
    of thing. So it’s kind of shocking why
  • 8:40 - 8:42
    they got into the vascular business. But
  • 8:42 - 8:46
    anyway, with SPY technology, what it does
  • 8:46 - 8:49
    is that it utilizes a fluorescent agent
  • 8:49 - 8:51
    that we inject into the patient, so after
  • 8:51 - 8:55
    the patient has had the
    revascularization procedure,
  • 8:55 - 8:57
    they follow up at the office, we inject
  • 8:57 - 8:59
    them with the fluorescent agent,
  • 8:59 - 9:01
    and what it does is that we’re able to put
  • 9:01 - 9:03
    this camera right on their feet, right
  • 9:03 - 9:08
    overhead, and it gives us
    this thermal imaging.
  • 9:08 - 9:11
    So when you see this right here, that’s
  • 9:11 - 9:14
    good news. Actually the redder, the more
  • 9:14 - 9:18
    red it is, the better it is. It means you
  • 9:18 - 9:19
    have really good flow.
  • 9:19 - 9:21
    And as the area gets a little bit blue,
  • 9:21 - 9:24
    that means you have diminishing blood
  • 9:24 - 9:27
    flow in that area. And when it gets to be
  • 9:27 - 9:31
    like this, you know you have a serious
  • 9:31 - 9:38
    problem. So this type of stuff is what
  • 9:38 - 9:40
    we’ve been doing for people in Miami,
  • 9:40 - 9:44
    for people in the Florida region.
  • 9:44 - 9:47
    And so I started to take this type of
  • 9:47 - 9:50
    practice back to Ghana.
  • 9:50 - 9:54
    Ghana is very interesting to me, not only
  • 9:54 - 9:57
    because I’m from Ghana,
  • 9:57 - 9:59
    but I’ve been very impressed with the
  • 9:59 - 10:01
    government of Ghana in terms of their
  • 10:01 - 10:05
    initiatives, which is a little bit
  • 10:05 - 10:08
    surprising to me because in those parts
  • 10:08 - 10:12
    of the world there’s a stigma that is
  • 10:12 - 10:14
    associated with individuals or persons
  • 10:14 - 10:16
    with disability.
  • 10:16 - 10:18
    Ghana is a small country in West Africa,
  • 10:18 - 10:21
    the population is about 28 million.
  • 10:21 - 10:25
    The GDP is about $130 billion. That puts
  • 10:25 - 10:27
    them at number 12 out of 52 of African
  • 10:27 - 10:30
    countries, and it’s actually the blueprint
  • 10:30 - 10:32
    for African democracy. It’s a
  • 10:32 - 10:34
    constitutional republic.
  • 10:34 - 10:39
    And English is the official language
    of the country.
  • 10:39 - 10:42
    About 15 percent of the Ghana population
  • 10:42 - 10:44
    are persons with disability.
  • 10:44 - 10:47
    In 2006, the country passed a disability
  • 10:47 - 10:51
    law, and the purpose for this was to end
  • 10:51 - 10:55
    discrimination against individuals with
  • 10:55 - 10:58
    disability in the country.
  • 10:58 - 11:01
    The country has been working very very
  • 11:01 - 11:03
    hard to improve the living conditions
  • 11:03 - 11:05
    of individuals that live there.
  • 11:05 - 11:09
    My foundation, what we’ve done is that,
  • 11:09 - 11:13
    we’re really focusing on, because
  • 11:13 - 11:15
    disabilities, there are so many causes of
  • 11:15 - 11:20
    disabilities, from congenital diseases to
  • 11:20 - 11:23
    hereditary diseases and also acquired
  • 11:23 - 11:26
    diseases. With the acquired diseases,
  • 11:26 - 11:28
    my focus is really on the
  • 11:28 - 11:30
    noncommunicable diseases, because it
  • 11:30 - 11:32
    really falls in line with something we
  • 11:32 - 11:35
    have knowledge on. So what I've done is
  • 11:35 - 11:37
    that I’ve invested my own money into
  • 11:37 - 11:41
    building a hospital. This is a rendering,
  • 11:41 - 11:45
    a rendition, of the hospital,
    the deGraft Research Hospital,
  • 11:45 - 11:47
    and the purpose of this hospital
  • 11:47 - 11:48
    is to facilitate the work that we
  • 11:48 - 11:52
    have done very successfully in Florida.
  • 11:52 - 11:55
    This is more images, and this is the
  • 11:55 - 11:57
    current progress of the hospital.
  • 11:57 - 11:59
    So hopefully by the end of next year
  • 11:59 - 12:00
    we will complete this project,
  • 12:00 - 12:03
    and then we will be able to offer the same
  • 12:03 - 12:07
    things we offer the people of Florida,
  • 12:07 - 12:11
    in Ghana. Thank you.
Title:
vimeo.com/.../277682681
Video Language:
English
Team:
ABILITY Magazine
Duration:
12:28

English subtitles

Revisions Compare revisions